Long-Term Prednisolone Therapy in Children with Idiopathic Pulmonary Hemosiderosis
Autor: | Ravikumar E, Saha, Ponnaiya J, Anand Date, Khanduri U, Raghupathy P |
---|---|
Rok vydání: | 1993 |
Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment Respiratory disease Splenectomy Hematology Iron deficiency Hemosiderosis medicine.disease Gastroenterology Surgery Oncology Internal medicine Pediatrics Perinatology and Child Health medicine Prednisolone Plasmapheresis business Tranexamic acid medicine.drug Rare disease |
Zdroj: | Pediatric Hematology and Oncology. 10:89-91 |
ISSN: | 1521-0669 0888-0018 |
DOI: | 10.3109/08880019309016532 |
Popis: | Idiopathic pulmonary hemosiderosis (IPH) is a rare disease of unknown etiology characterized by the triad of iron deficiency anaemia, hemoptysis, and pulmonary infiltrates.1 Effective therapy remains elusive although oral iron therapy;1,2 corticosteroids,1,2 tranexamic acid,1 desferrioxamine,1 diet free of cow's milk,3 and nebulized saline,2 plasmapheresis,1 splenectomy,2 and chloro-quine4 have all been tried. Long-term steroid treatment has not been recommended.2 We describe our experience with three recent cases of IPH treated with prednisolone. |
Databáze: | OpenAIRE |
Externí odkaz: |